Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kazuki, Tomura"'
Autor:
Kazuki Tomura, Hirokazu Ikeda, Toru Watanabe, Nao Tanaka, Ayako Suzuki, Yumiko Kusunoki, Sachiko Tanaka, Tadanori Sasaki, Risa Yamauchi, Mariko Awaya, Hironori Tanaka
Publikováno v:
Clinical Nephrology. 96:289-295
AIM The new guidelines in Japan do not recommend a vancomycin (VCM) loading dose for patients with an estimated glomerular filtration rate (eGFR) 30 < and ≤ 80 mL×min-1×1.73m-2 (moderate renal dysfunction) or administration to those with the eGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1450dd3ebc13e66f2570b39beada657a
https://doi.org/10.5414/cn110475
https://doi.org/10.5414/cn110475
Autor:
Kazuki Tomura, Hironori Tanaka, Tadanori Sasaki, Mariko Awaya, Hisato Fujihara, Yumiko Kusunoki, Toru Watanabe, Nao Tanaka, Makoto Hayashi, Hirokazu Ikeda
Publikováno v:
The Showa University Journal of Medical Sciences. 32:207-213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebdcfe79465b5cfcbf6278c15ae26bfe
https://doi.org/10.15369/sujms.32.207
https://doi.org/10.15369/sujms.32.207
Autor:
Yumiko Ogawa, Tomiko Sunaga, Masahiro Usuda, Kazuki Tomura, Tadanori Sasaki, Yuki Naito, Hiroyuki Sakamaki, Akiko Nagatani, Nao Akiyama, Mari Kogo, Tatsuya Kurihara, Haruaki Sasaki, Tatsunori Murata
Publikováno v:
YAKUGAKU ZASSHI. 138:1397-1407
Sunitinib has been shown to offer clinical benefits during the treatment of advanced renal cell carcinoma. However, molecular targeting drugs are expensive and can have a significant impact on medical expenses. The purpose of this study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4df8437356e8575c0fd3877059a6f04
https://doi.org/10.1248/yakushi.17-00189
https://doi.org/10.1248/yakushi.17-00189
Autor:
Kazuki, Tomura, Yuki, Naito, Tomiko, Sunaga, Tatsuya, Kurihara, Masahiro, Usuda, Akiko, Nagatani, Yumiko, Ogawa, Nao, Akiyama, Haruaki, Sasaki, Tatsunori, Murata, Hiroyuki, Sakamaki, Mari, Kogo, Tadanori, Sasaki
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 138(11)
Sunitinib has been shown to offer clinical benefits during the treatment of advanced renal cell carcinoma. However, molecular targeting drugs are expensive and can have a significant impact on medical expenses. The purpose of this study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5564d325c0d85e60fdf6a69019b4ca31
https://pubmed.ncbi.nlm.nih.gov/30381648
https://pubmed.ncbi.nlm.nih.gov/30381648
Autor:
Kazuki Tomura, Yuki Naito, Mari Kogo, Naokazu Fujii, Akiko Nagatani, Touji Hashimoto, Yumiko Ogawa, Tadanori Sasaki, Tomiko Sunaga, Takayuki Okabe
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 137(2)
Radiotherapy (RT) and chemoradiotherapy (CRT) is widely accepted as the standard treatment for head and neck cancer (HNC). Oral mucositis (OM) often develops as an adverse reaction in HNC patients that receive RT or CRT involving S-1. However, little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e1a4b26c7513635a6dfc1496558449
https://pubmed.ncbi.nlm.nih.gov/28154335
https://pubmed.ncbi.nlm.nih.gov/28154335
We consider the effect of characteristics of prison inmates in general and the job training program participation in particular on the recidivism in Japan. By employing individual level dataset from a Kawagoe Juvenile Correctional Facility, we find t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc68717e30d7ac0e653fd3ec21d08809
